Furthermore, one of the most intriguing findings of our study was the identification of a higher proportion of CPFE ANA + patients that also exhibited positive ANCAs (n = 7/40, 17.5%) against MPO compared to IPF patients without emphysema (n = 0) (p < 0.05). This evidence concerns the gene MPO and pulmonary emphysema.